Evidence map›Paper›PMID 34438939›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Identification of Antibiotics in Surface-Groundwater. A Tool towards the Ecopharmacovigilance Approach: A Portuguese Case-Study.

Paula Viana, Leonor Meisel, Ana Lopes, Rosário de Jesus, Georgina Sarmento, Sofia Duarte, Bruno Sepodes, Ana Fernandes, Margarida M Correia Dos Santos, Anabela Almeida and 1 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Biotransformation of Antibiotics byAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Paula VianaAgência Portuguesa do Ambiente (APA), Rua da Murgueira, 9, Zambujal, Alfragide, 2610-124 Amadora, Portugal.
Leonor MeiselAutoridade Nacional do Medicamento e Produtos de Saúde, I.P. (INFARMED), Avenida do Brasil, 53, 1749-004 Lisboa, Portugal.ORCID 0000-0001-5645-1298
Ana LopesAgência Portuguesa do Ambiente (APA), Rua da Murgueira, 9, Zambujal, Alfragide, 2610-124 Amadora, Portugal.
Rosário de JesusAgência Portuguesa do Ambiente (APA), Rua da Murgueira, 9, Zambujal, Alfragide, 2610-124 Amadora, Portugal.
Georgina SarmentoLaboratório de Análises, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
Sofia DuarteCentro de Investigação Vasco da Gama (CIVG), Departamento de Ciências Veterinárias, Escola Universitária Vasco da Gama (EUVG), Campus Universitário de Lordemão, Av. José R. Sousa Fernandes 197, 3020-210 Coimbra, Portugal.ORCID 0000-0003-2597-6651
Bruno SepodesFaculdade de Farmácia, Universidade de Lisboa, Avenida Prof. Gama Pinto, 1649-004 Lisboa, Portugal.ORCID 0000-0002-2761-0955
Ana FernandesLaboratório de Análises, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
Margarida M Correia Dos SantosLaboratório de Análises, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.ORCID 0000-0001-7531-757X
Anabela AlmeidaCentro de Investigação Vasco da Gama (CIVG), Departamento de Ciências Veterinárias, Escola Universitária Vasco da Gama (EUVG), Campus Universitário de Lordemão, Av. José R. Sousa Fernandes 197, 3020-210 Coimbra, Portugal.ORCID 0000-0002-7394-3785
M Conceição OliveiraCentro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.ORCID 0000-0002-3068-4920

Funding

"Melhoria da avaliação do estado das massas de água" Project POSEUR-03-2013-FC-000001Portuguese Mass Spectrometry Network LIS-BOA-01-0145-FEDER-022125-IST
6 · The paper itself

Abstract

Environmental monitoring, particularly of water, is crucial to screen and preselect potential hazardous substances for policy guidance and risk minimisation strategies. In Portugal, extensive data are missing. This work aimed to perform a qualitative survey of antibiotics in surface- groundwater, reflecting demographic, spatial, consumption and drug profiles during an observational period of three years. A passive sampling technique (POCIS) and high-resolution chromatographic system were used to monitor and analyse the antibiotics. The most frequently detected antibiotics were enrofloxacin/ciprofloxacin and tetracycline in surface-groundwater, while clarithromycin/erythromycin and sulfamethoxazole were identified only in surface water. The detection of enzyme inhibitors (e.g., tazobactam/cilastatin) used exclusively in hospitals and abacavir, a specific human medicine was also noteworthy. North (Guimarães, Santo Tirso and Porto) and South (Faro, Olhão and Portimão) Portugal were the regions with the most significant frequency of substances in surface water. The relatively higher detection downstream of the effluent discharge points compared with a low detection upstream could be attributed to a low efficiency in urban wastewater treatment plants and an increased agricultural pressure. This screening approach is essential to identify substances in order to perform future quantitative risk assessment and establishing water quality standards. The greatest challenge of this survey data is to promote an ecopharmacovigilance framework, implement measures to avoid misuse/overuse of antibiotics and slow down emission and antibiotic resistance.

Indexed as

abacavirantibioticscilastatinecopharmacovigilancePOCISsurface- groundwatertazobactam

Identifiers

PMID34438939
PMCPMC8388677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.